deltatrials
Completed PHASE1 NCT00309855

Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

Mechanisms of Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men: Modulation of GHRH, GHRP and Somatostatin Action by Estrogenic Versus Androgenic Steroids

Sponsor: GlaxoSmithKline

Conditions Aging
Interventions Anastrazole Dutasteride Placebo Testosterone
Updated 5 times since 2017 Last updated: Jul 27, 2012 Started: Dec 31, 2005 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This PHASE1 trial investigates Aging and is currently completed. GlaxoSmithKline leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
  • Mayo Clinic
Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Rochester, United States